Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in disease, today announced that multiple abstracts will ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
Abstract: Current memristive circuits for biological decision-making only consider simple situations and do not take into account how the organisms themselves learn these behaviors. In this article, a ...
4d
Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong ...
Tissue Cryopreservation Preserves More Future Options The way a patient's tumor tissue is preserved after surgery is ...
AVAI, BIOA, NAGE, LLY, and NVO Lead a New Wave of Metabolic and Molecular Anti-Aging Therapies Issued on behalf of Avaí Bio, Inc. Companies mentioned in this article: Avaí Bio, Inc. (OTCQB: AVAI), ...
The School of Engineering and Technology, CMR University, Bengaluru, invites applications to its B.Tech programmes.
Abstract: The digital transformation process fostered by the development of Industry 4.0 technologies has largely affected the health sector, increasing diagnostic capabilities and improving drug ...
DAVIE, FL / ACCESS Newswire / April 7, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO" or the "Company"), a clinical-stage biotechnology company, today announced its selection as a Qualified Team adva ...
Girl group Mamamoo will launch a large-scale world tour beginning on June 19 to mark its 12th debut anniversary, the group announced Friday through its official social media channels. An announcement ...
The Gairdner Foundation today announced the nine 2026 Canada Gairdner Award laureates, honouring world-leading scientists whose pioneering biomedical and global health research has transformed our ...
First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results